Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This thing has to follow all of the other recovering biotech companies. Just cleaned up on RPRX, buying at 1.64 and selling at 2.55. This has more promise than they do, that is if they hear nothing tomorrow.
Happy Thanksgiving to you and everybody here.
We might get a really good bounce after the Thanksgiving holiday and weekend. Happy Thanksgiving to all of Celladon Corporation shareholders and investors.
From Bullrider2.
I'm curious as to how you come up with 1.56. Like I've said, I don't understand charts.
So far so good today. Not expecting much with the holiday week.
CLDN - 100% buy short term on Bar Chart.
http://www.barchart.com/opinions/stocks/CLDN
Good EOD volume, solid in the $1.40s today.
CLDN
SS
You can call this stock Dave Matthews by the way you see it CRASHHHHH! Haha. :P
Solid support in the mid $1.40s today, lite volume
CLDN
SS
I have noticed. It seems like they control the trading range with the block. Rarely goes below or above where that MM parks
Have you noticed all the 5600 orders that the mm GSCO has on both the bid and the ask? They've had them every since I've been in CLDN and I'm wondering why. Any thoughts?
I'm not a chartist but it looks to me like resistance is @1.60.
There was an 18,000 sh block on the ask @1.60 but now it's gone.
Green! CLDN! HOD!
It looks like it's ready to run hard!
CLDN!
About to go green !!
Welcome to the board, mantisforce. You're fortunate to get shs at this level. My average is quite a bit higher.
I am buyer at these prices, lets see if it pans out. happy thanksgiving :)
Dip and rip buyers will be coming !
CLDN is holding up well considering that it's a holiday week.
Red to green... What a surprise??? I dont understand why people still fall for those dips at the open.
Congrats on the cheap shs. Yes, it usually dips early in the day. Yesterday it dipped to 1.12 and shortly afterwards ran up to 1.74.
Let's hope to see the $2's today.
Added 1.44 PM. Wont be surprised to see CLDN dip red at the start. It makes a R/G move ever day.
It looks like there won't be a gap after all but that's good. We won't have to think about a gap needing to be filled.
2.08 seems like a good price target for the day. I'm thinking we see a nice pop around 11am past $2 if pressure keeps up on the shorts.
Good morning! It's nice to see that CLDN is up pre-mkt. This will be a nice green day!
Barchart shows 1st resistance @1.79 and 2nd resistance @2.08.
http://www.barchart.com/cheatsheet.php?sym=CLDN
$1.64 pre market ! Gapper ?? Gl all
Only few shares now
Pre-market: 1.64 +0.13 (8.61%
https://www.google.com/finance?q=cldn&ei=JUlUVpCzCYOXeay3gKAE
After the merger is finalized and/or the results of the phase 2 clinical trials are positive, I believe that level and higher. That may not be for 3-6 months down the road. Near term $ 2+ possible with current S/S and the 37M cash on hand.
CLDN
SS
just researching this one...can it get to six?
Welcome as a mod. The I-Box looks good.
I forgot that this is a short week. We'd most likely need news for it to move up to $3 this quick but we never know. It hit $3 pre-mkt last Thursday.
Yes, it was. It wouldn't surprise me at all if we hit $3 this week.
Looks like $1.58 close ah !
Bid/Ask - 1.57/1.58 AH.
Rsi @ 74.99 ~
I still believe we see $2 tomorrow.
CLDN!
Yep, I'm eager. Somebody is accumulating lots of shs.
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1047
|
Created
|
12/03/14
|
Type
|
Free
|
Moderators |
About the Proposed Merger
Existing Eiger stockholders as well as investors in the contemporaneous financing will receive newly issued shares of Celladon common stock in connection with the proposed merger. Celladon is expected to issue approximately 85.0 million new shares of its common stock to Eiger stockholders and participants in the financing. On a pro forma basis for the combined company, current Celladon shareholders are expected to own approximately 22%, current Eiger shareholders approximately 45% and the new Eiger investor syndicate approximately 33%, each on a fully-diluted basis.
The transaction has been unanimously approved by the boards of directors of both companies, and a majority of Eiger stockholders have agreed to vote in favor of the transaction. The proposed merger is expected to close in the first half of 2016, subject to the approval of the stockholders of each company as well as regulatory approval and other customary conditions. The merger agreement contains further details with respect to the proposed merger.
Celladon’s exclusive financial advisor in the transaction is Wedbush PacGrow Healthcare. Jefferies LLC is acting as lead financial advisor to Eiger and Piper Jaffray is acting as financial advisor. Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to Celladon and Cooley LLP served as legal counsel to Eiger.
Chart
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |